KLAC
56
11
PSA
45
2
SYY
41
-2
CVX
14
-11
O
20
-6
PEG
55
2
BMY
38
-3
NTRS
39
2
TAP
54
-3
KMX
54
-10
REGN
44
2
JNJ
35
5
NI
67
2
PCG
61
2
NWS
75
4
STI
21
9
VFC
53
-3
UNH
44
2
WDC
40
3
FFIV
63
2
KLAC
56
11
PSA
45
2
SYY
41
-2
CVX
14
-11
O
20
-6
PEG
55
2
BMY
38
-3
NTRS
39
2
TAP
54
-3
KMX
54
-10
REGN
44
2
JNJ
35
5
NI
67
2
PCG
61
2
NWS
75
4
STI
21
9
VFC
53
-3
UNH
44
2
WDC
40
3
FFIV
63
2
Financhill
Back

Atara Biotherapeutics 10K Form

Sell
41

ATRA
Atara Biotherapeutics

Last Price:
$13.17
Seasonality Move:
10.83%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ATRA News And Ratings

See the #1 stock for the next 7 days that we like better than ATRA

ATRA Financial Statistics

Sales & Book Value

Annual Sales: $8.6M
Cash Flow: $-4M
Price / Cash Flow: 0
Annual Sales: $-15.77
Price / Book: 0

Profitability

EPS (TTM): -25.76000
Net Income (TTM): $-133.2M
Gross Margin: $-313K
Return on Equity: 0%
Return on Assets: -85.41%

Atara Biotherapeutics Earnings Forecast

Key Atara Biotherapeutics Financial Ratios

  • The Gross Profit Margin over the past 6 years for ATRA is -3.65%.
  • The Selling, General & Administrative Expenses for ATRA have been equal to 593.82% of Gross Profit Margin.
  • The Research & Development expenses have been 2,622.01% of Revenue.
  • The Interest Expense is -1.91% of Operating Income.
  • The Net Earning history of ATRA is -3,220.88% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 4 years.

Atara Biotherapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ATRA
CUSIP: 046513
Website: atarabio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0.59
Quick Ratio: 0.44

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ATRA Technical Analysis vs Fundamental Analysis

Sell
41
Atara Biotherapeutics (ATRA) is a Sell

Is Atara Biotherapeutics a Buy or a Sell?